Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12.

(2017) M. Gnant et al.   JOURNAL OF CLINICAL ONCOLOGY

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial

(2008) Nicholas D. James et al.   BJU INTERNATIONAL

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

(2008) B Sherrill et al.   BRITISH JOURNAL OF CANCER

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer — A Multi-Arm Multi-Stage Randomised Controlled Trial

(2008) N.D. James et al.   CLINICAL ONCOLOGY

Interim monitoring of efficacy data is important and appropriate

(2008) Matthew R. Sydes et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Early stopping of randomized clinical trials for overt efficacy is problematic

(2008) Dirk Bassler et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

(2008) Tomasz Burzykowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Speeding up the Evaluation of New Agents in Cancer

(2008) M. K. B. Parmar et al.   JNCI-Journal of the National Cancer Institute

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

(2008) Anders Widmark et al.   LANCET